St. Lambert, Canada

Sébastien Goudenege

This inventor holds 1 USPTO granted patent. Top assignee: Universitè Laval. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sébastien Goudenege. Retrieved from https://idiyas.com/inventor/sébastien-goudenege

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Myogenic Differentiation by Sébastien Goudenege

Introduction

Sébastien Goudenege is an accomplished inventor based in Saint-Lambert, Canada. He has made significant contributions to the field of stem cell research, particularly in the differentiation of stem cells into muscle cells. His innovative work has the potential to impact regenerative medicine and transplantation therapies.

Latest Patents

Sébastien Goudenege holds a patent titled "Myogenic differentiation of stem cells and uses thereof." This patent discloses methods for differentiating stem cells into muscle cells by growing the cells in a specialized myogenic culture medium. The differentiated muscle cells can serve as a valuable source for transplantation in patients requiring muscle regeneration.

Career Highlights

Goudenege is affiliated with Université Laval, where he conducts research and develops his innovative ideas. His work is at the forefront of stem cell technology, contributing to advancements in medical treatments and therapies.

Collaborations

Sébastien has collaborated with notable colleagues, including Jacques P Tremblay and Nicolas B Huot. These partnerships enhance the research and development of his innovative projects.

Conclusion

Sébastien Goudenege's contributions to the field of stem cell differentiation represent a significant advancement in medical science. His patent and ongoing research hold promise for future applications in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…